Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy

Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy

Self-nanoemulsifying drug delivery system (SNEDDS) have been considered as a promising platform for oral delivery of many BCS (biopharmaceutics classification system) class IV drugs, such as docetaxel (DTX). However, oral chemotherapy with DTX is also restricted by its active P-glycoprotein (P-gp) e...

Full description

Bibliographic Details
Main Authors: Weiping Cui, Hanqing Zhao, Chen Wang, Yao Chen, Cong Luo, Shenwu Zhang, Bingjun Sun, Zhonggui He
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
docetaxel (dtx)
cyclosporine a
snedds
co-loaded
oral chemotherapy
Online Access:http://dx.doi.org/10.1080/10717544.2019.1616237

Internet

http://dx.doi.org/10.1080/10717544.2019.1616237

Similar Items